ProCE Banner Activity

HCV Alert: New Data on Resistance to DAAs and Implications for Therapy

Slideset Download
In this downloadable slideset, Nezam H. Afdhal, MD, FRCPI, provides guidance on testing for and management of resistance in HCV-infected patients treated with DAA therapy.

Released: October 30, 2015

Expiration: October 28, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Janssen